Ciprofloxacin treatment of urinary infections results in increased resistance of urinary E. coli to ciprofloxacin and co-trimoxazole

Polish Journal of Microbiology

Volumn 58, Issue 4, 2009, Pages 371-373

  Borgmann, Stefan ^a   Jakobiak, Thomas ^a   Gruber, Heribert ^a   Schröder, Helmut ^b   Sagel, Ulrich ^c  

^a SYNLAB ACADEMY   (Germany)

^b Wissenschaftliches Institut der AOK WIdO   (Germany)

^c AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

Author keywords

Antibiotic prescription; Ciprofloxacin; Co trimoxazole; E. Coli; Urinary infection

Indexed keywords

CEFACLOR; CIPROFLOXACIN; COTRIMOXAZOLE; FOLIC ACID ANTAGONIST;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BIOSTATISTICS; CROSS RESISTANCE; ESCHERICHIA COLI; GERMANY; HUMAN; NONHUMAN; OUTPATIENT CARE; PRESCRIPTION; SEASONAL VARIATION; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; GERMANY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; TIME FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; UROPATHOGENIC ESCHERICHIA COLI;

EID: 77649212228     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Borgmann S., T. Jakobiak, H. Gruber, H. Sehröder and U. Sagel. 2009. Prescriptions of broad-spectrum antibiotics to outpatients do not match increased prevalence and antibiotic resistance of respiratory and urinary pathogens in Bavaria (Southern Germany). Pol. J. Microbiol. 58: 105-110.
2. Farra A., G. Skoog, L. Wallén, G. Kahlmeter, G. Kronvall, M. Sörberg and Swebact Study Group. 2002. Antibiotic use and Escherichia coli resistance trends for quinolones and cotrimoxazole in Sweden. Scand. J. Infect. Dis. 34: 449-455.
3. Huang E.S. and R.S. Stafford. 2002. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Arch. Intern. Med. 162: 41-47.
4. Kahlmeter G. and P. Menday. 2003. Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J. Antimicrob. Chemother. 52: 128-131.
5. Karlowsky J.A., D.J. Hoban, M.R. Decorby, N.M. Laing and G.G. Zhanel. 2006. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study. Antimicrob. Agents Chemother. 50: 2251-2254.
6. Kern W.V. and Schröder H. 2008. Antibiotic consumption in human medicine. 2.1. Antibiotic consumption in ambulatory settings (in German). In: Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Paul-Ehrlich-Gesellschaft für Chemotherapie e.V., 8. Infektiologie Freiburg Eds. GERMAP 2008. Antibio tic resistance and consumption (in German). Antiinfectives Intelligence, Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH, Rheinbach, Germany
7. Kresken M. and Straube E. 2008. Antibiotic resistance in human medicine (in German) 4.1.4. Haemophilus influenzae. In: Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Paul-Ehrlich-Gesellschaft für Chemotherapie e.V., Infektiologie Freiburg Eds. GERMAP 2008. Antibiotic resistance and consump tion (in German). Antiinfectives Intelligence, Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH, Rheinbach, Germany
8. Livermore D.M., P. Stephens, J. Weinberg, A.P. Johnson, T. Gifford, D. Northcott, D. James, R.C. George and D.C Speller. 2000. Regional variation in ampicillin and trimethoprim resistance in Escherichia coli in England from 1990 to 1997, in relation to antibacterial prescribing. J. Antimicrob. Che mother. 46: 411-422.